Evidence-Based Medicine and the American Thoracic Society Clinical Practice Guidelines
The American Thoracic Society (ATS) issues clinical practice guidelines for the care of patients with pulmonary and critical care disease. The utility of ATS guidelines depends on the quality of the evidence base underpinning recommendations and whether the guidelines permit the practice of evidencebased medicine (EBM). 1, 2 However, the extent to which ATS guidelines are substantiated by high-quality evidence and can be used to promote EBM is unknown.
Methods | Two of 3 investigators (R.C.S., K.D., and A.N.M.) reviewed each ATS clinical practice guideline recommendations listed on the ATS website as of August 1, 2017 , that pertained to adults. 3 We abstracted the following domains necessary for evidence-based clinical decision making based on prior conceptual frameworks We defined recommendations as including the basic set of EBM measures if they included at least 1 measure of test performance for diagnostic recommendations (sensitivity, specificity, or likelihood ratio) and at least 1 measure of absolute benefit or harm for therapeutic recommendations (absolute risk reduction/increase, number needed to treat/harm, or relative risk with incidence of the outcome for the control group). For patient context, we ascertained whether the narrative text included any discussion of a person's severity of illness or comorbidities, sociopersonal context, prognosis, or personal preference and how these domains might influence the recommendation. 1 Differences between reviewers were resolved through negotiated consensus, aiming to achieve agreement using the most inclusive definitions. Two-sided P < .05 for descriptive statistics indicated significance.
Results | Among 222 unique recommendations from 16 separate guidelines, 141 (63.5%) were based on low-quality evidence, whereas fewer than 1 in 10 (19 [8.6%]) were based on high-quality evidence ( Table 1) . Nonetheless, 86 (38.7%) were designated strong recommendations. Higher quality of evidence was associated with an increased probability of receiving a strong recommendation; 29 of 141 low-quality evidence recommendations (20.6%), 41 of 62 moderate-quality evidence recommendations (66.1%), and 16 of 19 highquality evidence recommendations (84.2%) were strongly recommended (P < .001 for trend). However, most strong recommendations were not supported by high-quality evidence Abbreviations: ATS, American Thoracic Society; EBM, evidence-based medicine. a Classified using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) score except the guideline for community-acquired pneumonia (CAP), which used strong (most patients should receive the intervention), medium, and weak (many health care professionals would not follow this recommendation) categories. CAP recommendations of medium or weak were reclassified as low/conditional.
b Classified using the 4 GRADE categories, combining low-and very-low-quality ratings into a single low category, given the similar uncertainty and because several ATS guidelines only used 1 of these categories. c Includes diagnostic, therapeutic, screening (n = 3), and monitoring (n = 3) recommendations. One recommendation included both a therapeutic and diagnostic recommendation. Table 2 ). The community-acquired pneumonia guideline had the most recommendations (n = 47), had the highest proportion supported by high-quality evidence (15 [31.9%]), and accounted for 15 of 19 total recommendations supported by high-quality evidence.
Discussion | The ATS clinical practice guidelines are supported by suboptimal evidence and often are not presented in a manner suitable to optimize care for individual patients. Although 38.7% of recommendations are strong, fewer than 1 in 10 are supported by high-quality evidence (ie, a randomized controlled trial or a meta-analysis). Apart from communityacquired pneumonia, only 4 recommendations were supported by high-quality evidence among the 175 recommendations for all other pulmonary and critical care conditions combined.
The main limitation of our study was that we overestimated the frequency that recommendations included EBM measures and patient context domains, because we did not require meaningful and complete information in these areas. For example, if a recommendation mentioned consideration of costs, we credited the recommendation for including discussion of a patient's sociopersonal context.
Our study has several implications. First, most ATS guidelines should be cautiously applied and should not be considered standard of care, given the paucity of high-quality evidence. Future randomized clinical trials could lead to reversal of many recommendations, even for tests and therapies that are currently strongly recommended. 5 Further, standardizing poorly substantiated diagnostic tests or treatments can lead to inappropriate and harmful care. 6 Second, future ATS guideline committees should strive to adhere to best practices for EBM, which include a transparent discussion of diagnostic test characteristics, treatment effectiveness, and relevant patient context domains to help guide clinical decision making. 2 Third, our framework can be used by guideline development checklists and methodology reports to ensure future guidelines adheres to EBM principles. 
